The role of antifibrotic therapies in the treatment of systemic sclerosis–associated interstitial lu...
The role of antifibrotic therapies in the treatment of systemic sclerosis–associated interstitial lung disease
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Systemic sclerosis (SSc) is a rare autoimmune condition with complex pathogenesis characterized by a heterogeneous presentation and different disease courses. Fibrosis of multiple organs including the lungs favored by inflammation and vasculopathy is the hallmark of SSc. SSc-associated interstitial lung disease (SSc-ILD) is common and can be associ...
Alternative Titles
Full title
The role of antifibrotic therapies in the treatment of systemic sclerosis–associated interstitial lung disease
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_269f144ac245417f86fb41b6106e0403
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_269f144ac245417f86fb41b6106e0403
Other Identifiers
ISSN
1759-720X
E-ISSN
1759-7218
DOI
10.1177/1759720X211066686
